PETER THIEL Insider Trading $ANCN Chemomab Therapeutics Ltd.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PETER THIEL.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PETER THIEL. PETER THIEL is Director in Palantir Technologies Inc. ($PLTR) and Director in Facebook Inc ($FB) and 10% Owner in Chemomab Therapeutics Ltd. ($ANCN) and Director in AbCellera Biologics Inc. ($ABCL).

PETER THIEL in Chemomab Therapeutics Ltd.

Trading Symbol: ANCN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER THIEL: 10% Owner
Holdings: 1,108,509 shares
Latest Transaction: Mar 18 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PETER THIEL in Chemomab Therapeutics Ltd.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ABCL, ANCN, FB, PLTR

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 18 2021ANCNChemomab Therapeut ...THIEL PETER10% OwnerOption ExerciseP17.3523,054400,00823,054
Mar 18 2021ANCNChemomab Therapeut ...THIEL PETER10% OwnerBuyP0.00230,53601,108,509878 K to 1.1 M (+26.26 %)

Page:   1